The Mind-Gut Conversation Podcast

Ulcerative colitis is still one of the hardest subjects for women to talk about, and two women who have lived with it for years are done staying quiet.In this episode of The Mind-Gut Conversation, Dr. Emeran Mayer is joined by Chloe Melas, an NBC News correspondent, and Judy Batalion, a New York Times bestselling author, to talk about living with ulcerative colitis, a form of inflammatory bowel disease (IBD). Their book, The Girl's Guide to Guts, is out November 10.They share how each of them got sick, from Judy's sudden onset at age 12 to Chloe's diagnosis in her twenties, and what they wish their doctors had told them. Dr. Mayer explains how stress reactivity, the microbiome, and the brain-gut-microbiome system may relate to flares, and gives his view on fecal microbial transplants, turmeric, gut-directed hypnosis, and functional medicine. The conversation also covers dating, intimacy, fertility, pregnancy, and the overlap between IBS and IBD.Topics discussed include:• Living with ulcerative colitis: two very different diagnosis stories• Why gut disease is still stigmatized for women• Stress, anxiety, and the brain-gut-microbiome system in IBD• Fecal microbial transplants and where they stand for IBD• Turmeric, gut-directed hypnosis, and other alternative therapies• IBD, intimacy, fertility, and pregnancy• How IBS and IBD overlapThis is a candid, patient-centered conversation for anyone living with ulcerative colitis, IBD, or IBS, and for the people who care for them.You can get Chloe & Judy's book here: https://www.thegirlsguidetoguts.com/----------------------------Connect with Dr. Mayer:Website: https://www.emeranmayer.comInstagram: https://www.instagram.com/emeranmayer/X: https://x.com/emeranmayermdFacebook: https://www.facebook.com/EmeranMayerMD/LinkedIn: https://www.linkedin.com/in/emeranmayer/----------------------------Chapters:0:00 - Introduction1:25 - Two Paths to Ulcerative Colitis: How Chloe and Judy Got Sick9:01 - Why Gut Disease Is Still Hard for Women to Talk About16:03 - What Patients Wish Their Doctors Had Told Them25:02 - Fecal Transplants and Alternative Therapies for IBD38:00 - Intimacy, Fertility, Pregnancy, IBS, and Daily Life With IBD

Some people with digestive symptoms at home eat pasta, bread, and pizza in Italy without a problem. Why?In this episode of The Mind-Gut Conversation, Dr. Emeran Mayer sits down with his son Dylan Mayer, co-founder of Mayer Nutrition, in a café on the Piazza del Popolo in Fermo, Italy, during the olive harvest. They talk about what happens to digestion when we travel and what the Mediterranean lifestyle may have to teach us.Dr. Mayer draws on decades of travel and clinical experience to explain how stress, sleep, and uncertainty can reach the gut through the brain-gut system. They discuss jet lag and the microbiome, the gap between gluten sensitivity at home and abroad, how they eat on travel days, and why olive oil quality varies so much between producers.The conversation closes with a simple habit for anyone who wants their next trip to be easier on their gut.Topics discussed include:• Why travel can cause constipation, diarrhea, and other digestive changes• How stress, sleep, and uncertainty reach the gut through the brain-gut system• What jet lag may do to the microbiome• Gluten, food fears, and why symptoms can differ from one country to another• How to eat on travel days and what to bring with you• How harvest timing changes the polyphenol content of olive oil• Why the Mediterranean lifestyle is more than a diet• One habit to try on your next tripThis is a practical conversation for anyone who wants to travel without packing their food anxiety along with their luggage.Products mentioned in the episode:The Mayer ModelDr. Mayer and Dylan wrote The Mayer Model around the idea that healthy longevity comes from several habits working together: diet, daily movement, and a sense of community. The same pattern shows up in the Italian towns they visit in this episode. Read it before your next trip. Get it on Amazon (https://a.co/d/03pprYfx)Mayer Nutrition's Extra Virgin Olive OilThis is the oil Dylan and Dr. Mayer brought with them to Fermo. It’s an organic, early-harvest, unblended Italian extra virgin olive oil from 500-year-old trees in the Marche region. Early harvest matters because riper olives give more oil but fewer polyphenols. Drizzle it over finished dishes. Get it at Mayer Nutrition (https://mayernutrition.com)Chapters:0:00 - Introduction1:19 - Why Travel Disrupts Digestion3:36 - Gluten, Jet Lag, and Food Fears8:45 - Dr. Mayer's Routine When Traveling11:35 - Eating Locally and the Olive Harvest15:13 - The Mediterranean Lifestyle16:52 - Advice For Eating When Traveling18:50 - Polyphenols in The Mediterranean Diet19:50 - Dr. Mayer's Opinion on Alcohol21:21 - Food Anxiety & Biohacking Fatigue23:25 - Live Like a Local24:30 - Dr. Mayer's One Recommendation to Try on Your Next Trip

Nutrition advice seems to change every week, but Dr. Christopher Gardner says the core of what we know has barely moved in fifty years.In this episode of The Mind-Gut Conversation, Dr. Mayer talks with Gardner, a professor of medicine at Stanford University, about his new book, Food Sense. Gardner has studied nutrition for more than three decades, served on the Dietary Guidelines Advisory Committee, and sits on the scientific advisory board of the Culinary Institute of America. He is not selling a product, and he makes the case that there is much more consensus in nutrition than social media suggests.They discuss what GLP-1 weight loss drugs may and may not change about our relationship with food, whether you need animal protein to stay strong and active, and where protein anxiety comes from. They also look at the research on dairy and fermented foods, why the word inflammation is thrown around so freely, and how politics shapes the dietary guidelines.Topics discussed include:• Why Gardner says there is more agreement in nutrition than the headlines show• What we know and don’t know about GLP-1 drugs• Plant protein, animal protein, and the fiber gap• Dairy, lactose intolerance, and fermented foods• Inflammation, seed oils, and what the evidence supports• How industry and politics influence what we are told to eatIf you have ever felt anxious in a grocery aisle or at a restaurant table, this conversation offers a calmer way to think about food.His new book, Food Sense, is available on Amazon October 13th, 2026! -----------------------------------------Connect with Dr. Mayer:Website: https://www.emeranmayer.comInstagram: https://www.instagram.com/emeranmayer/X: https://x.com/emeranmayermdFacebook: https://www.facebook.com/EmeranMayerMD/LinkedIn: https://www.linkedin.com/in/emeranmayer/-----------------------------------------Chapters:0:00 - Introduction4:00 - The Main Message of Food Sense9:42 - GLP-1 Drugs and the Food Environment21:13 - Plant Protein vs. Animal Protein35:12 - Food Politics, Dietary Guidelines, and Dairy44:37 - Fermented Foods, Inflammation, and Seed Oils54:27 - Closing: What Gardner Eats

Over the past century, average lifespan in Western countries has grown by about 30 years. The years we spend in good health have not kept pace.In this episode of The Mind–Gut Conversation, Dr. Mayer is joined by Dr. Jamie Justice, Executive Vice President of the Health Domain at the XPRIZE Foundation and Executive Director of XPRIZE Healthspan, a $101 million, seven-year global competition to find therapies that restore muscle, cognitive, and immune function in older adults.They discuss the roughly 12-year gap between lifespan and healthspan, why research in worms, flies, mice, and non-human primates suggests aging may be modifiable, and how the XPRIZE competition model rewards teams for demonstrated results rather than proposals. Dr. Justice explains why she does not consider aging a disease, why lifestyle interventions and new therapies should be tested side by side, and what it would take to separate evidence from hype in the consumer longevity market.The conversation closes with the bigger questions: how long humans could realistically live, and how society needs to rethink purpose, work, and technology as more people live into their 80s, 90s, and beyond.Topics discussed include:• Why healthspan has not kept up with lifespan• How the XPRIZE Healthspan competition works• Why aging is a risk factor, not a disease• Lifestyle interventions vs. new longevity therapies• Evidence standards in the consumer longevity market• The limits of lifespan extension and what it means for societyThis is a practical, science-driven discussion for anyone interested in longevity, healthy aging, and the future of aging research.------------------------------This episode is sponsored by Mayer Nutrition, co-founded by Dr. Emeran Mayer. Polyphenols are the plant compounds found in berries, cocoa, green tea and olive oil, and most of their value comes from what happens in your gut: your microbes convert them into compounds your body can absorb and use. Mayer Nutrition makes food and nutrition products built on Dr. Mayer's research into the brain-gut-microbiome system.Save 10% with code MINDGUT. Learn more at mayernutrition.com.------------------------------Chapters:0:00 - Introduction3:37 - Why Has Interest in Longevity Surged?7:02 - Healthspan vs. Lifespan14:35 - Inside the XPRIZE Healthspan Competition24:26 - Lifestyle Interventions vs. New Therapies37:49 - Is Aging a Disease?48:30 - How Long Could Humans Live?56:01 - Closing Remarks

After 45 years of research on how the brain and the gut communicate, the question Dr. Emeran Mayer hears most often is not about mechanisms or studies. It is much simpler than that. People tell him they understand the science, they just do not know how to live it.In this episode of The Mind-Gut Conversation, Dr. Mayer introduces The Mayer Model, the book he has been working toward for his entire career. He explains why his earlier books, The Mind-Gut Connection and The Gut-Immune Connection, focused on explaining the biology, and why this one is built to close the gap between the evidence and the ordinary decisions people make every day about food, stress, sleep, movement, and recovery.He traces the long view of how the idea of a bidirectional brain-gut conversation went from a fringe interest to one of the most active areas in biomedical research, and how the discovery of the gut microbiome as a third participant reorganized the entire model. Food is not simply fuel. It is information that trillions of microbes transform into signals that reach every organ, including the brain.The Mayer Model is not a diet and not a protocol. It is a systems-based way of understanding your own biology clearly enough to make better decisions inside it. Across seven chapters, the book covers the role of diet in shaping the brain-gut-microbiome system, gut-healthy recipes, and detailed guidance on building a gut-healthy lifestyle through movement, sleep, contemplative practices, and vagal stimulation.Dr. Mayer also shares who he wrote the book for, and how listeners can access a set of launch-window bonuses, including a live Q&A over Zoom, a guided meditation, a recipe guide, and a Mayer Nutrition coupon.The Mayer Model is available now on Amazon: https://a.co/d/0bkjOcxPLaunch bonuses: https://themayermodel.com/ Topics discussed include:• Why understanding gut science is not the same as applying it• How brain-gut research moved from the fringe to the mainstream• The gut microbiome as the third participant in the brain-gut conversation• What The Mayer Model is, and what it is not• What is inside the seven chapters of the book• Who the book is for, and how to claim the launch bonusesThis episode is brought to you by Mayer Nutrition. We believe real food comes first. A diverse, plant-forward diet is the foundation of a healthy brain-gut-microbiome system, and everything we make is designed to support that foundation rather than replace it. When you want extra support, Mayer Nutrition offers science-informed products like Synaptic Bloom and our proprietary extra virgin olive oil. Use code MINDGUT for 10% off your first order at www.mayernutrition.comConnect with Dr. Mayer:Website: https://www.emeranmayer.comInstagram: https://www.instagram.com/emeranmayer/X (Twitter): https://www.x.com/emeranmayermdFacebook: https://www.facebook.com/EmeranMayerMD/LinkedIn: https://www.linkedin.com/in/emeranmayer/Chapters:0:00 - Introduction1:04 - The Long View: 45 Years of Brain-Gut Research2:12 - The Third Participant: The Gut Microbiome3:15 - From Explanation to Application4:03 - What Is The Mayer Model?5:25 - Who This Book Is For6:12 - How to Get the Book and Launch Bonuses

Modern medicine has never been better at keeping people alive. So why are we spending more of our lives unwell?In this episode of The Mind-Gut Conversation, Dr. Emeran Mayer examines a new analysis from the Global Burden of Disease project, published in Lancet Public Health, comparing how long people live with how many of those years are lived in good health across 204 countries and territories.The difference between those two numbers is called the morbidity gap. In 1990 the average person could expect to spend 8.8 years of life in poor health. By 2023 that had risen to 10.7 years, and the gap widened in 203 of the 204 places studied. The wealthiest countries fare worst of all, with the United States leading globally at 14 years.Dr. Mayer explains what is actually driving those unhealthy years, why the trend now extends across the entire adult lifespan rather than clustering in old age, and why two of the largest contributors sit squarely within the brain-gut-microbiome system.Topics discussed include:• What the morbidity gap is and how it is measured• Why the 45-year-old compression of morbidity hypothesis is being challenged• Why high-income countries carry the largest health gaps• The five conditions responsible for most unhealthy years worldwide• Why health decline is starting in middle age• The gender health paradox• Why years lived may be the wrong scoreboardThis is a science-driven discussion for anyone interested in healthspan, healthy aging, and chronic disease prevention.---------------------------This episode is sponsored by Mayer Nutrition. Food comes first, always. For the places where diet leaves a gap, use code MINDGUT for 10% off your first order.---------------------------Chapters:0:00 - Introduction1:00 - What This Study Set Out to Test2:23 - The Morbidity Gap Explained3:35 - Why Wealthy Countries Rank Worst5:05 - Health Decline in Middle Age6:10 - What Fills the Unhealthy Years7:28 - Men, Women, and the Health Gap8:31 - Rethinking How We Measure Success9:39 - Closing Thoughts11:25 - A Word From Our Sponsor

For most of the last forty years, irritable bowel syndrome was treated as a problem of the gut alone. The idea that the brain plays a central role took decades to gain acceptance, and it remains contested today.In this episode of The Mind-Gut Conversation, Dr. Mayer is joined by Dr. Erin Mauney, a pediatric gastroenterologist and researcher at Harvard and Massachusetts General Hospital, who has completed one of the first clinical trials of psilocybin-assisted therapy for patients with treatment-resistant IBS.They discuss why a compound acting primarily on the brain might change how the gut is experienced, what happens when the brain’s prediction machinery becomes locked into a cycle of pain and anticipation, and why the therapy surrounding the dosing sessions may matter as much as the molecule itself.The conversation also takes on the harder questions. How do you run a placebo-controlled trial when every participant knows they received the drug? Can the psychedelic experience be engineered out of psychedelic medicine, and what is lost if it is? And what can practices used ritually for millennia still teach a reductionist Western model of care?This is early-stage science, and Dr. Mauney is refreshingly clear about the limits of what is currently known. It is also a glimpse at what the next chapter of brain-gut medicine might look like.Topics discussed include:• Why IBS is best understood as a disorder of gut-brain interaction• How the brain’s predictive coding can become locked into chronic pain• What psilocybin-assisted therapy actually involves, session by session• Whether the psychedelic experience itself is essential to the benefit• The placebo problem in psychedelic trials, and why it may be unsolvable• How long the benefits appear to last after treatment ends• Where psychedelic research in gastroenterology may be headedThis is a careful, evidence-based conversation for anyone interested in IBS, chronic pain, and the future of brain-gut medicine.Chapters:0:00 - Introduction3:23 - IBS as a Brain-Gut Disorder7:40 - Entering Psychedelic Research13:22 - How Psilocybin Could Affect the Gut15:43 - Inside the Trial17:50 - The Brain and Pain Prediction21:18 - Side Effects and Patient Experience25:40 - Does the Psychedelic Experience Matter?29:57 - Ritual and Western Medicine32:15 - The Placebo Question36:33 - Combining Therapies39:10 - Brain Imaging40:56 - Practical Challenges44:07 - Durability of Benefits47:23 - Overlap With Other Conditions49:28 - Where the Research Goes Next54:11 - Looking Ahead

Millions of people take a daily probiotic without ever asking a basic question: does any of it survive long enough to do anything?In this episode of The Mind-Gut Conversation, Dr. Mayer is joined by Kiran Krishnan, a research microbiologist and Chief Scientific Officer at Microbiome Labs who has spent his career studying the human microbiome and the science behind probiotics. Kiran is best known for popularizing spore-based probiotics and for his work on metabolic endotoxemia, the mechanism behind what many people call leaky gut.The conversation opens with a hard look at what happens to probiotics in the stomach. Kiran describes testing 40 of the leading probiotic brands under standard gastric conditions and finding that none of the strains survived the passage intact. From there they examine why CFU counts have become the industry's main marketing lever despite telling consumers almost nothing, why multi-strain formulas can cause individual strains to cancel each other out, and why some probiotic strains may trigger an inflammatory response rather than calm one.They also address one of the most persistent myths in the field, the idea that probiotics colonize the gut and reseed the microbiome. Kiran explains why nearly all probiotics, including spores, are transient, and what that means for how these products should actually be evaluated.The second half turns to the missing microbes hypothesis: the argument that modern agriculture has stripped soil-derived spore-forming bacteria out of our food supply, along with the tilling, monocropping, and synthetic fertilizer practices driving that loss. Dr. Mayer and Kiran connect the health of the soil to the health of the gut, and close with practical guidance on how an ordinary consumer can evaluate a probiotic in an unregulated market.Topics discussed include:Why most probiotics do not survive stomach acidWhat CFU counts really tell you, and what they do notWhy multi-strain formulas can work against themselvesThe myth of probiotic colonization and reseeding the microbiomeHow modern agriculture changed the soil microbiomeHow to evaluate a probiotic before you buy itThis is a candid, evidence-based conversation for anyone interested in gut health, the microbiome, and separating probiotic science from probiotic marketing.--------------------------------------------------------------------This episode is brought to you by Mayer Nutrition. Use code MINDGUT to save 10% on your first order of Synaptic Bloom.--------------------------------------------------------------------Chapters:0:00 - Introduction2:23 - The Missing Microbes Hypothesis and the Role of Spores11:51 - Why Most Probiotics Don't Survive the Stomach20:24 - The Problem With Multi-Strain Formulas27:41 - How Modern Agriculture Changed Our Soil43:14 - Colonization, Survival, and What the Evidence Shows50:03 - How to Choose a Probiotic That Actually Works

Menopause isn't just hot flashes — it's brain fog, bone loss, sleep, mood, and your gut. In this solo episode of The Mind-Gut Conversation, Dr. Emeran Mayer unpacks the ~34 symptoms of perimenopause and menopause, the 2002 hormone-therapy scare that still shapes care today, and what current science says about estrogen and HRT.Then he turns to the part almost no one is talking about: the estrobolome — the gut microbes that recycle estrogen as part of the brain-gut microbiome system. It may explain why symptom severity varies so widely between women, and why fiber, phytoestrogens, soy isoflavones, and equol point toward a new generation of non-hormonal menopause treatments.A myth-busting, hopeful look at what we get wrong about menopause — and the science finally setting it right.Key Topics Covered:The ~34 symptoms of perimenopause and menopauseThe 2002 WHI study and the hormone-therapy backlashWhat current science says about estrogen, HRT, and vaginal estrogenThe estrobolome and how the gut recycles estrogenPhytoestrogens, equol, and fiber as non-hormonal leversWhy there's real reason for hopeChapters:0:00 – How many symptoms does menopause really have?2:21 – Why menopause care was abandoned for a generation4:40 – The 2002 scare & what we know now about hormone therapy7:05 – The estrobolome: how your gut recycles estrogen7:50 – A non-hormonal approach: phytoestrogens & Dr. David Meriwether's research10:25 – Fiber, ultra-processed foods & the probiotic myth11:45 – The reframe & the equity gap in menopause care14:05 – Reasons for hopeConnect with Dr. Mayer:Website: https://www.emeranmayer.comInstagram: https://www.instagram.com/emeranmayer/X: https://www.x.com/emeranmayermdFacebook: https://www.facebook.com/EmeranMayerMD/LinkedIn: https://www.linkedin.com/in/emeranmayer/

This episode is brought to you by Mayer Nutrition. Use code MINDGUT at checkout to save 10% on your first order of our polyphenol blend, Synaptic Bloom, at https://www.mayernutrition.com.The health of our soil and the health of our gut may be expressions of the same crisis — and healing one may depend on healing the other.In this episode of The Mind–Gut Conversation, Dr. Mayer continues his conversation with Sadhguru, recorded at the Isha Foundation in Tennessee, turning from consciousness and inner intelligence to the ground beneath us — quite literally. Sadhguru has spent years leading the Save Soil movement, one of the most far-reaching environmental campaigns in recent history, reaching nearly four billion people in a hundred days.In this conversation, they explore why the collapse of microbial life in our soil, the chlorination of our water supply, and the devitalization of our food may be driving a slow, generational deterioration in human health — one that science is only beginning to measure. Sadhguru argues that the soil crisis and the gut health crisis are not separate problems, but deeply intertwined expressions of the same disconnect from the living systems that sustain us. Dr. Mayer traces how that impoverishment travels from the earth to the root, to the gut, to the brain.Topics discussed include:Why soil degradation and gut health are part of the same crisisHow the loss of microbial life in soil, water, and food affects human biologyThe gut-soil continuum and what ancient yogic science understood about the microbiomeWhether the Save Soil movement can outpace the speed of environmental declineWhy Sadhguru believes science and spirituality are searching for the same truthWhat it means to live at full capacity — from microbe to human beingConnect with Dr. Mayer:Website: https://www.emeranmayer.comInstagram: https://www.instagram.com/emeranmayer/X: https://www.x.com/emeranmayermdFacebook: https://www.facebook.com/EmeranMayerMD/LinkedIn: https://www.linkedin.com/in/emeranmayer/Chapters:0:00 - Introduction1:45 - Is the Save Soil Movement Enough to Turn the Tide?5:30 - Human Well-Being Is What's in Peril9:00 - The Gut-Soil Continuum13:00 - What Ancient Yogic Science Knew About Microbial Life16:30 - Chlorinated Water, Devitalized Food, and Generational Health19:30 - You Are a Walking Lump of Soil22:00 - Where Science and Spirituality Meet